Wednesday, July 8, 2026

pharma · Alcohol Use Disorder · CMND

Clearmind Medicine

Clearmind Medicine is a pharma organization headquartered in Vancouver, CA. It trades on NYSE under ticker CMND. Primary therapeutic focus areas include Alcohol Use Disorder. NovaPharmaNews links 1 clinical program(s), 0

Vancouver, CA HQ
2021 Founded
7 Employees
Public company Type
CMND · NYSE Ticker
Company details
Status
Public
HQ
Vancouver, CA
Founded
2021
Employees
7
Programs
1
Drugs
1
Patents
5
Clinical program

CMND-100

Phase 2 · small molecule · Alcohol Use Disorder

CMND-100 for Alcohol Use Disorder is a Phase 2 program (small_molecule) at Clearmind Medicine with 1 ClinicalTrials.gov record(s).

← All Clearmind Medicine projects Phase 2 small molecule active

Internal code CM-CMND-001

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Clearmind Medicine
Phase
Phase 2
Modality
small_molecule
Indication
Alcohol Use Disorder
Status
active
Trials
1